Published Erratum Epublish
PubMed: 42583123 DOI: 10.3389/fphar.2026.1939779
Correction: Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.
Front Pharmacol 17:1939779
Authors: Giuseppe d'Orsi, Maria Teresa Di Claudio, Alessia Cafaro, Sebastiano Barco, Marta Robustella, Nicolò Locatelli, Antonella Liantonio, Paola Imbrici, Grazia Ciavarella, Antonio Rinaldi, Giuseppe Fania, Umberto Costantino, Massimo Carella, Giuliana Cangemi, Giuseppe Miscio
Affiliations
- Neurology Unit - Epilepsy Center, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotond, Italy.
- Biochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analyses, IRCCS Istituto Giannina Gaslini, Genova, Italy.
- Department of Pharmacy - Drug Sciences, University of Bari "Aldo Moro", Bari, Italy.
- Medicina Trasfusionale e Laboratorio Analisi, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
- UOC Genetica Medica, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
Abstract
[This corrects the article DOI: 10.3389/fphar.2026.1830217.].
MeSH
Drug Resistant Epilepsy, Epilepsy, Pharmacogenetics, Pharmaceutical Preparations, Drug Monitoring, Precision Medicine, Therapeutics